Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON)

BACKGROUND: Extended-release naltrexone (XR-NTX, Vivitrol®) and daily oral naltrexone tablets (O-NTX) are FDA-approved mu opioid receptor antagonist medications for alcohol dependence treatment. Despite the efficacy of O-NTX, non-adherence and poor treatment retention have limited its adoption into...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Contemp Clin Trials
Main Authors: Malone, Mia, McDonald, Ryan, Vittitow, Alex, Chen, Jenny, Obi, Rita, Schatz, Daniel, Tofighi, Babak, Garment, Ann, Kermack, Andrea, Goldfeld, Keith, Gold, Heather, Laska, Eugene, Rotrosen, John, Lee, Joshua D.
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701869/
https://ncbi.nlm.nih.gov/pubmed/30986535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2019.04.006
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki